TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33506929

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (L. rhamnosus GG) administered postoperatively for 30 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard nutrition
Number of subjects: 40
Study: 35487078

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over left frontal pole (LFP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Motor cortex rTMS
Number of subjects: 24
Study: 33891478

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (5 weekly cycles of carboplatin and paclitaxel with concurrent radiotherapy at 41.4 Gy in 23 fractions, 5 days per week) followed by surgery
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 366

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 366
Study: 33089619

Group type: EXPERIMENTAL
Intervention: Thermocoagulation
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 149
Study: 35142560

Group type: EXPERIMENTAL
Intervention: Exercise bout before vaccination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (rest before vaccination)
Number of subjects: 60
Study: 34545701

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1138
Study: 36011679

Group type: EXPERIMENTAL
Intervention: Microcurrent therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham microcurrent stimulation
Number of subjects: 30
Study: 32936533

Group type: EXPERIMENTAL
Intervention: Test metformin hydrochloride tablet (0.25 g)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Reference metformin hydrochloride tablet (0.25 g)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High-fat and high-calorie diet
Number of subjects: 56
Study: 36440744

Group type: EXPERIMENTAL
Intervention: Action observation therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mirror therapy and action observation
Number of subjects: 12
Study: 32331505

Group type: EXPERIMENTAL
Intervention: Educational software
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Educational booklet
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study: 32046899

Group type: EXPERIMENTAL
Intervention: EEG-NFB protocol aimed at increasing the low-Î²(SMR)/high-Î² ratio, n = 16
Number of subjects: 32

Group type: COMPARATOR
Intervention: EEG-NFB protocol aimed at increasing the Î±(Î¼)/Î¸ ratio, n = 16
Number of subjects: 32
Study: 35334953

Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet for eight weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo during double-blinded provocations
Number of subjects: 19
Study: 32294394

Group type: EXPERIMENTAL
Intervention: Greek yogurt with granola (150 kcal, 9.2 g protein, 2.6 g fat, 2.0 g dietary fibre, and 21.5 g available carbohydrate/100 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cultured coconut product with granola (146 kcal, 3.2 g protein, 3.2 g fat, 5.6 g dietary fibre, and 21.9 g available carbohydrate/100 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 24
Study: 33593220

Group type: EXPERIMENTAL
Intervention: Percutaneous microwave ablation (MWA)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Nomogram and ANN model
Number of subjects: 496
Study: 33221899

Group type: EXPERIMENTAL
Intervention: CEDs with warning labels
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Warnings on the back of CED cans featuring large font, a border, and a 'caution' heading
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Front‐of‐package 'High source of caffeine' labels
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Qualitative caffeine statement
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Existing warning statements in Canada
Number of subjects: 2040
Study: 33892599

Group type: EXPERIMENTAL
Intervention: FACT intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 33814283

Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 80% COZD
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 90% COZD
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 90-100% COZD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 60% COZD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 70% COZD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 60% and 70% COZDs
Number of subjects: 32
Study: 33242444

Group type: EXPERIMENTAL
Intervention: D-VTd
Number of subjects: 1085

Group type: COMPARATOR
Intervention: VTd
Number of subjects: 1085
Study: 35262874

Group type: EXPERIMENTAL
Intervention: HRV Biofeedback (HRV-BF)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 84
Study: 34059090

Group type: EXPERIMENTAL
Intervention: iTBS + VCT
Number of subjects: 23
Study: 32845825

Group type: EXPERIMENTAL
Intervention: Ecological-belonging intervention
Number of subjects: 1822

Group type: COMPARATOR
Intervention: Business-as-usual controls
Number of subjects: 1822
Study: 36011491

Group type: EXPERIMENTAL
Intervention: My Jump 2 app in standing position
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: My Jump 2 app in standardized position
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mean observations in each height
Number of subjects: 39
Study: 35257001

Group type: EXPERIMENTAL
Intervention: Self-guided, online single-session mental health interventions (SSIs) in a randomized controlled trial (RCT) where participants were paid for participation
Number of subjects: 2436

Group type: COMPARATOR
Intervention: Self-guided, online single-session mental health interventions (SSIs) in a program evaluation project where participants were not paid for participation
Number of subjects: 2436
Study: 35870236

Group type: EXPERIMENTAL
Intervention: Minimal group paradigm
Number of subjects: 192

Group type: COMPARATOR
Intervention: Minimal group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Real-world social groups (gender or race)
Number of subjects: 192
Study: 34773880

Group type: EXPERIMENTAL
Intervention: Parasacral transcutaneous electrical stimulation
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tibial transcutaneous electrical stimulation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sham group (active electrode placed over the scapula)
Number of subjects: 99
Study: 36038984

Group type: EXPERIMENTAL
Intervention: EHA cream (1% ectoine and 0.1% hyaluronic acid), applied twice daily for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vehicle cream, applied twice daily for 4 weeks
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: EHA cream (1% ectoine and 0.1% hyaluronic acid)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: EHA cream
Number of subjects: 70
Study: 32919819

Group type: EXPERIMENTAL
Intervention: Protocol-guided individualized nutritional support during the hospital stay
Number of subjects: 1995

Group type: COMPARATOR
Intervention: Hospital food as usual (control group)
Number of subjects: 1995
Study: 35062921

Group type: EXPERIMENTAL
Intervention: Power 4 a Healthy Pregnancy (P4HP) intervention group
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 350
Study: 33246390

Group type: EXPERIMENTAL
Intervention: Family navigation
Number of subjects: 275

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 275
Study: 34429230

Group type: EXPERIMENTAL
Intervention: ultrasound + PICCO
Number of subjects: 68

Group type: COMPARATOR
Intervention: PICCO
Number of subjects: 68
Study: 33076287

Group type: EXPERIMENTAL
Intervention: Genotype B3 measles virus strains identified through RT-PCR amplification
Number of subjects: 3258

Group type: EXPERIMENTAL
Intervention: Molecular surveillance
Number of subjects: 3258

Group type: EXPERIMENTAL
Intervention: Intensive vaccination program
Number of subjects: 3258
Study: 32171308

Group type: EXPERIMENTAL
Intervention: Interdisciplinary graded exposure program
Number of subjects: 30
Study: 32672654

Group type: EXPERIMENTAL
Intervention: Graft-free short tunnel small flap (STSF) technique
Number of subjects: 203

Group type: COMPARATOR
Intervention: Scleral patch graft (SPG) technique
Number of subjects: 203
Study: 35060528

Group type: EXPERIMENTAL
Intervention: Standard care plus methylene blue
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study: 34151132

Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant afatinib (30 mg by mouth daily)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 2 years of adjuvant afatinib (30 mg by mouth daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (3 months of afatinib)
Number of subjects: 46
Study: 35550036

Group type: EXPERIMENTAL
Intervention: Neoadjuvant proton radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant carbon ion radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0
Study: 34280455

Group type: EXPERIMENTAL
Intervention: Palonosetron (0.075 mg)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Ondansetron (8 mg)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Palonosetron and Ondansetron
Number of subjects: 212
Study: 33093133

Group type: COMPARATOR
Intervention: Conscious sedation
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 368
Study: 34459904

Group type: EXPERIMENTAL
Intervention: States that lifted eviction moratorium
Number of subjects: 509694

Group type: EXPERIMENTAL
Intervention: Individuals with Charlson Comorbidity Index score of 3 or greater
Number of subjects: 509694

Group type: EXPERIMENTAL
Intervention: Individuals living in nonaffluent areas
Number of subjects: 509694

Group type: EXPERIMENTAL
Intervention: Individuals living in areas with high rent burden
Number of subjects: 509694

Group type: COMPARATOR
Intervention: States that did not lift eviction moratorium
Number of subjects: 509694
Study: 36442063

Group type: EXPERIMENTAL
Intervention: Remdesivir plus SOC (ACTT-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir plus SOC (ACTT-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir plus dexamethasone plus SOC (ACTT-3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus SOC (ACTT-1)
Number of subjects: 0
Study: 32313940

Group type: EXPERIMENTAL
Intervention: Letrozole-based COS
Number of subjects: 401

Group type: COMPARATOR
Intervention: Conventional COS
Number of subjects: 401

Group type: COMPARATOR
Intervention: Random-cycle start COS
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: GnRHa trigger
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Thawing of oocytes or embryos
Number of subjects: 401

Group type: COMPARATOR
Intervention: All-cause survival
Number of subjects: 401
Study: 35102203

Group type: COMPARATOR
Intervention: FC rt‐fMRI neurofeedback with online global signal regression (GSR)
Number of subjects: 40
Study: 36401133

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (NIVO + IPI)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy (NIVO + Chemo)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Chemotherapy (Chemo)
Number of subjects: 394
Study: 33058746

Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) including manual lymphatic drainage (MLD) before bandaging, 15 sessions over 3 weeks.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard therapy (ST) including compressive multilayer bandaging and exercise training, 15 sessions over 3 weeks.
Number of subjects: 54
Study: 32535341

Group type: EXPERIMENTAL
Intervention: Intervention group (body positioning changed in the second and fourth hour after chemoembolization)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Intervention group (body positioning changed)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (usual care, lying supine)
Number of subjects: 78
Study: 36206832

Group type: EXPERIMENTAL
Intervention: Dynamic Neuromuscular Stabilization (DNS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Core Stabilization (CS)
Number of subjects: 64
Study: 33499572

Group type: EXPERIMENTAL
Intervention: VR video intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: General video intervention
Number of subjects: 84
Study: 32548906

Group type: EXPERIMENTAL
Intervention: Fit & Strong! program (exercise combined with health education)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Non-participants (those who declined participation)
Number of subjects: 82
Study: 35580566

Group type: EXPERIMENTAL
Intervention: Obese children with 0 components of MetS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Obese children with 1 component of MetS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Obese children with 2 or more components of MetS
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (healthy peers)
Number of subjects: 90
Study: 34022854

Group type: EXPERIMENTAL
Intervention: Combined motor control and isolated extensor strengthening (MC + ILEX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: General exercise (GE)
Number of subjects: 50
Study: 32388446

Group type: EXPERIMENTAL
Intervention: Glucosamine 1g/day for 1 week and 2g/day for 3 weeks
Number of subjects: 20
Study: 35241047

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factors (CGF) combined with Deproteinized Bovine Bone Mineral (DBBM)
Number of subjects: 38

Group type: COMPARATOR
Intervention: DBBM alone (Control group)
Number of subjects: 38
Study: 33277845

Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy
Number of subjects: 116

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy
Number of subjects: 116
Study: 34344672

Group type: EXPERIMENTAL
Intervention: HCQ 200 mg/day + BHH 8 mg/8 hours
Number of subjects: 214

Group type: COMPARATOR
Intervention: HCQ placebo + BHH placebo
Number of subjects: 214
Study: 33262458

Group type: EXPERIMENTAL
Intervention: Hybrid-particle-in-cell (PIC) - Monte Carlo Collision (h-PIC-MCC) algorithm
Number of subjects: 0
Study: 34076333

Group type: COMPARATOR
Intervention: Chlorthalidone (C)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Amlodipine (A)
Number of subjects: 491
Study: 32586613

Group type: EXPERIMENTAL
Intervention: Maitland joint mobilization technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Home based training group
Number of subjects: 30
Study: 35765728

Group type: EXPERIMENTAL
Intervention: 30 ml of 0.3% ropivacaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 40 ml of 0.3% ropivacaine
Number of subjects: 40
Study: 34448759

Group type: EXPERIMENTAL
Intervention: IPL + PDL
Number of subjects: 33

Group type: COMPARATOR
Intervention: PDL
Number of subjects: 33
Study: 33242998

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) with U-500R
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous injection (SC) of U-500R
Number of subjects: 0
Study: 33199427

Group type: EXPERIMENTAL
Intervention: ACT-based video game intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative questionnaires
Number of subjects: 0
Study: 35954926

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Freeze-Dried Bone Allograft (FDBA)
Number of subjects: 10
Study: 34407782

Group type: EXPERIMENTAL
Intervention: Enhanced Mobile Technology Plus (MT+) intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Basic Mobile Technology (MT) intervention
Number of subjects: 80
Study: 32235839

Group type: EXPERIMENTAL
Intervention: Concise scoring method based on factors such as hyperbilirubinemia, sepsis, and ventilator and/or vasoactive support in the discovery cohort (n=4,151).
Number of subjects: 8320

Group type: EXPERIMENTAL
Intervention: Validation cohort scoring method.
Number of subjects: 8320
Study: 34180245

Group type: EXPERIMENTAL
Intervention: Intensive day-camp intervention arm
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard intervention arm
Number of subjects: 115
Study: 34989150

Group type: EXPERIMENTAL
Intervention: Acute distress group
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (higher emotional eating)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (higher emotional eating and increased acute distress)
Number of subjects: 47
Study: 32086599

Group type: EXPERIMENTAL
Intervention: CHO‐L (carbohydrate loaded)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: CHO‐D (carbohydrate depleted)
Number of subjects: 5
Study: 33200772

Group type: EXPERIMENTAL
Intervention: Telephone-delivered behavioral self-regulation counseling
Number of subjects: 251

Group type: COMPARATOR
Intervention: In-office behavioral self-regulation counseling
Number of subjects: 251

Group type: COMPARATOR
Intervention: Both interventions (telephone and in-office)
Number of subjects: 251
Study: 33379191

Group type: EXPERIMENTAL
Intervention: Modified fasting (extended distribution: 522 kcal total; bulking: 512 kcal total)
Number of subjects: 17

Group type: COMPARATOR
Intervention: True fasting (nil‐caloric intake)
Number of subjects: 17
Study: 35356935

Group type: EXPERIMENTAL
Intervention: Acupuncture plus antihypertensive drugs
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antihypertensive drugs only
Number of subjects: 70
Study: 33166769

Group type: EXPERIMENTAL
Intervention: Baseline glucose level
Number of subjects: 62
Study: 35410189

Group type: EXPERIMENTAL
Intervention: Monthly Clinical Supervision for up to two years
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control sites (no Clinical Supervision)
Number of subjects: 12
Study: 33631541

Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) plus 28 days of tailored booster messaging
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control condition (community resource brochure)
Number of subjects: 63
Study: 33753657

Group type: EXPERIMENTAL
Intervention: Sealants placed with bonding agent
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sealants placed without bonding agent
Number of subjects: 25
Study: 35899211

Group type: COMPARATOR
Intervention: 5% topical minoxidil (MX) alone, once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Minoxidil plus oral spironolactone (SPT) 80–100 mg daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Minoxidil plus microneedling (MN) every 2 weeks, 12 sessions
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MX + SPT group
Number of subjects: 120
Study: 33879327

Group type: EXPERIMENTAL
Intervention: Split-screen monitoring
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Avatar monitoring
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 52
Study: 35873768

Group type: EXPERIMENTAL
Intervention: Coffee group (caffeine-containing beverage)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Juice group (non-caffeinated juice)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (pre- and post-EA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (week 4)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (week 2)
Number of subjects: 40
Study: 34719299

Group type: EXPERIMENTAL
Intervention: Web app
Number of subjects: 34
Study: 33115487

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Environments and wearable haptic devices (VERA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional treatment (manual therapy)
Number of subjects: 8
Study: 35922096

Group type: EXPERIMENTAL
Intervention: IG1
Number of subjects: 4268

Group type: EXPERIMENTAL
Intervention: IG2
Number of subjects: 4268

Group type: EXPERIMENTAL
Intervention: IG3
Number of subjects: 4268

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 4268
Study: 32894643

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/velpatasvir (SOF/VEL)
Number of subjects: 1427

Group type: COMPARATOR
Intervention: Sofosbuvir/ledipasvir (SOF/LDV)
Number of subjects: 1427
Study: 33217416

Group type: EXPERIMENTAL
Intervention: Low tidal volume mechanical ventilation (3 mL/kg 5 times/min, with positive end expiratory pressure of 5 cm H2O) during CPB
Number of subjects: 1501

Group type: COMPARATOR
Intervention: No ventilation strategy during CPB
Number of subjects: 1501

Group type: EXPERIMENTAL
Intervention: Low tidal volume mechanical ventilation during CPB
Number of subjects: 1501
Study: 33034145

Group type: EXPERIMENTAL
Intervention: Piroxicam (single dose 1–2 hours before frozen-thawed ET)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo (administered at the same time as piroxicam)
Number of subjects: 178
Study: 34420261

Group type: EXPERIMENTAL
Intervention: Ozonized water irrigation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline irrigation
Number of subjects: 50
Study: 32275720

Group type: EXPERIMENTAL
Intervention: Height (measured in centimeters)
Number of subjects: 3427

Group type: COMPARATOR
Intervention: Cognitive/noncognitive skills (mental health, risk preference, personality factors)
Number of subjects: 3427
Study: 32503502

Group type: EXPERIMENTAL
Intervention: New oral composition
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 35110393

Group type: COMPARATOR
Intervention: CVN424 (1 mg to 225 mg single doses; 25, 75, or 150 mg repeated daily doses for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CVN424 (dosing after a standardized high-fat meal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CVN424 (various doses)
Number of subjects: 0
Study: 33652705

Group type: EXPERIMENTAL
Intervention: Low-glycemic load diet (n = 28)
Number of subjects: 62

Group type: COMPARATOR
Intervention: High-glycemic load diet (n = 34)
Number of subjects: 62
Study: 33805076

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered diet program for stroke survivors
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Co-design workshops
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Support framework and resources specific to outcome of stroke
Number of subjects: 18